Are you Dr. Lester?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
820 Lester Ave
Ste 119
Saint Joseph, MI 49085Phone+1 269-385-0029Fax+1 269-985-0040
Summary
- Dr. Eric Lester, MD is an oncologist in Saint Joseph, Michigan. He is currently licensed to practice medicine in Michigan, Minnesota, and Illinois.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1975 - 1977- University of ChicagoResidency, Internal Medicine, 1972 - 1975
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1972
Certifications & Licensure
MI State Medical License 1991 - 2020
IL State Medical License 1973 - 2014
MN State Medical License 2011 - 2012
PA State Medical License Active through 2012
Clinical Trials
- Decitabine in Treating Patients With Myelofibrosis Start of enrollment: 2004 Sep 29
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
- Join now to see all
Publications & Presentations
PubMed
- 58 citationsEpidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck CancerEzra E.W. Cohen, Daniel J. Haraf, Rangesh Kunnavakkam, Kerstin M. Stenson, Elizabeth A. Blair
Journal of Clinical Oncology. 2010-07-10 - 16 citationsA randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinomaAmy C. Peterson, Helena Harlin, Theodore Karrison, Nicholas J. Vogelzang, James A. Knost
Investigational New Drugs. 2006-02-28 - 59 citationsProspective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)Stuart M. Lichtman, Donna Hollis, Antonius A. Miller, Gary L. Rosner, Chris A. Rhoades
Journal of Clinical Oncology. 2006-04-20
Professional Memberships
- Member
